Marion McNabb, DrPH, MPH

Marion McNabb, DrPH, MPH

Marion McNabb, DrPH, MPH , Cannabis Center of Excellence, Marion McNabb, DrPH, MPH Dr. McNabb is the President of the Cannabis Center of Excellence, Inc a Massachusetts-based 501c3 nonprofit organization that conducts citizen-science-focused population studies and programs in the areas of community engagement, medical cannabis, adult-use cannabis, and social justice in the cannabis industry. The CCOE serves as a virtual resource & network of cannabis industry professionals, academics, policymakers, healthcare providers, consumers, and patients who aim to break the stigma and advance social justice in the cannabis industry. www.cannacenterofexcellence.org. Dr. McNabb is also the CEO of 510 Innovations LLC, a research, data science, and education company working with the healthcare innovations, cannabis, and entheogenic plant medicine industries.
Dr. McNabb is the Cannabis Retail Appointee to the Massachusetts Cannabis Advisory Board until October 2023 and was appointed by the Treasurer of Massachusetts. Dr. McNabb is the Principal Investigator of six Cannabis research studies examining the reasons and impact of cannabis use among adult-use consumers and medical patients, veterans, and the impact of COVID on patients and consumers in Massachusetts and the United States, together with UMass Dartmouth. She sits on several academic advisory boards for academic cannabis educational and workforce training programs. Dr. McNabb has collaborated on Cannabis Research studies with academic partners UMass Dartmouth and Rider University in New Jersey and educational programs with Excelsior University, Holyoke Community College, BU, Wayne State University, and others. She is currently the Principal Investigator of the Healthcare Provider Medical Cannabis Knowledge, Attitudes, and Practices Study, run together with UMass Dartmouth and Medicinal Genomics. Dr. McNabb also has over 15 years of global public health experience working in the areas of digital health, HIV/AIDS, maternal and child health, and family planning, working primarily in Africa and Haiti. Dr. McNabb holds a DrPH from Boston University School of Public Health and an MPH from the Johns Hopkins University Bloomberg School of Public Health. You can learn more about Dr. McNabb through her LinkedIn page: https://www.linkedin.com/in/marion-mcnabb-drph-mph

Martin Lee, director of Project CBD

Martin Lee, director of Project CBD

Martin Lee, director of Project CBD & author of Smoke Signals: A social history of cannabus, Project CBD, Martin A. Lee is the co-founder and director of Project CBD (projectcbd.org), an educational nonprofit that focuses on cannabis science and therapeutics. Hs is author of several books, including Smoke Signals: A Social History of Marijuana – Medical, Recreational and Scientific, winner of the American Botanical Council’s James A. Duke Award for Excellence in Botanical Literature. A recipient of the Emerald Cup’s Lifetime Achievement Award, Lee is also co-founder of the media watch group FAIR (Fairness & Accuracy In Reporting), and the coauthor of Acid Dreams: The Complete Social History of LSD — The CIA, the Sixties and Beyond.

Dustin Sulak, DO

Dustin Sulak, DO

Dustin Sulak, DO, Healer.com, Dustin Sulak, D.O. is a traditional osteopathic physician and expert in integrative medicine. His clinical practice in Maine focuses on treating refractory conditions in adults and children. Dr. Sulak is an internationally-renowned expert in medical cannabis, the author of the first foundational text on its clinical use, Handbook of Cannabis for Clinicians: Principles and Practice, and a co-founder of Healer.com, a medical cannabis education resource. He is a passionate educator and leader in the field of medical cannabis, and serves on the board of directors of The Society of Cannabis Clinicians.

Michelle Sexton ND

Michelle Sexton ND

Michelle Sexton ND, University of California San Diego, Dr. Sexton is a Naturopathic Doctor, graduated from Bastyr University in Seattle, WA. She completed pre- and post-doctoral fellowships at the University of Washington, formally studying the endocannabinoid system and its implications for health for 6 years. Her NIH-funded pre-doctoral and postdoctoral research was on the topics of cannabinoids and their roles in neuroinflammation and neurodegeneration. She investigated cannabinoid impact on inflammatory markers and immune cell activation in patients Multiple Sclerosis. She has continued her research into health effects of cannabis at University of California San Diego (UCSD) as an Assistant Adjunct Professor in the Department of Anesthesiology. She sees patients at UCSD Center for Integrative Medicine where the Center has started the first “Cannabis Clinic” at a major medical institution.

Dr. Sexton has presented her research internationally in peer-reviewed journals. Dr. Sexton’s research, clinical practice and teaching focus on the endocannabinoid system and roles for integrative medicine, including cannabis, to treat a range of conditions. She continues to investigate the immunomodulatory, opioid-sparing and quality of life effects of cannabis in patients across the lifespan. She is a member of the International Cannabinoid Research Society, the International Association of Cannabinoid Medicine, the California Naturopathic Doctors Association, and the American Association of Naturopathic Doctors. She also maintains a private medical practice at Pain Trauma Institute in San Diego, CA. When not caring for patients or pursuing research activities, you can find her surfing, swimming, in the garden, paying music, or playing with grandchildren!

Connie McLaughlin-Miley PharmD, MBA

Connie McLaughlin-Miley PharmD, MBA

Connie McLaughlin-Miley PharmD, MBA, Independent Consultant, Since 2014, upon returning to her enduring interest in pharmacognosy, Dr. McLaughlin-Miley, as a clinician-researcher, educator and patient advocate, consults within the professional and patient communities to manage use of cannabinoids and other plant medicines. Typically, through her work with patients, across the spectrum of diseases as well as for general health and well-being, will provide education and guidance throughout the course of their experience. Following the available literature and using an evidence-based approach, she recommends cannabinoids and typically suggests appropriate formulations, dosing and titration to address patient-specific needs in areas such as infectious disease, women’s health, pain (opioid reduction and elimination), cancer and those issues related to chemotherapy and/or cancer experiences.

Dr. McLaughlin-Miley completed her Pharmacy education at the University of Michigan and a post-doctorate Fellowship in Health Economics and Outcomes Research with the University of South Carolina, Columbia and Glaxo-Smith Kline. She also earned a Master’s in Business Administration, focused on Health Policy, from the University of California, Irvine. For several years within the Bio-Pharmaceutical Industry, her research was focused on clinical and quality-of-life issues, and she has published across a variety of therapeutic areas including oncology, pain and women’s health.

Deborah Malka MD, PhD

Deborah Malka MD, PhD

Deborah Malka MD, PhD, CannabisPlus, Deborah Malka MD, PhD, has been a board-certified specialist in Integrative Holistic Medicine specializing in cannabis medical consultations for the past 15 years, consulting with over 30,000 patients to date. Her private practice, CANNABIS PLUS, provides medical cannabis and natural health consulting for a national client base via phone or telemedicine appointments. She is both a clinician and an educator in this specialty. She was the faculty director of the first comprehensive on-line continuing medical education course in Clinical Cannabinoid Medicine sponsored by the Society of Cannabis Clinicians. Her new academic textbook, “Medicinal Cannabis: Pearls for Clinical Practice” has just been released. Prior to clinical practice, Dr. Malka completed her PhD in Human Genetics from Columbia University, and studied both natural and traditional medicine, with degrees from the University of New Mexico School of Medicine and the Santa Fe College of Natural Medicine.

Bryan A. Krumm, MSN, CNP, RN, BC

Bryan A. Krumm, MSN, CNP, RN, BC

Bryan A. Krumm, MSN, CNP, RN, BC, Harmony Psychiatric, Bryan Krumm, CNP is the Director of Harmony Psychiatric in Albuquerque, NM. He specializes in treatment of PTSD and his focus is to empower people to take more control of their own Psychiatric Health by using Cannabis and supplements to support endocannabiniod function. He helped author New Mexico’s Medical Cannabis Law and has worked to help change Cannabis policies at both the US and World level. He was The Nurse Practitioner Journal’s “Author of the Year” in 2017 for his seminal article “Cannabis for posttraumatic stress disorder: A neurobiological approach to treatment”; and he was awarded The Supreme Court Press “Petition of the Month, July 2019” for: “Bryan Krumm v. the Drug Enforcement Agency (DEA)”, Recognizing the Medical Benefits of Marijuana. He has worked with thousands of New Mexicans to help them reduce and/or eliminate the need for psychotropic medications.

Dr. Uma Dhanabalan, MD MPH FAAFP MRO CMS

Dr. Uma Dhanabalan, MD MPH FAAFP MRO CMS

MD MPH FAAFP MRO CMS, Global Health & Hygiene Solutions, LLC /Uplifting Health & Wellness ,

Dr. Uma Dhanabalan
 MD MPH FAAFP MRO CMS
Global Health & Hygiene Solutions, LLC / Uplifting Health & Wellness
Founder/CEO
777 Concord Avenue Suite 106
Cambridge, MA  02138
(508) 444-2324
UPLIFTINGHealthandWellnesss.com
 
Dr. Dhanabalan is a highly respected and educated physician and known to most as Dr Uma. She completed her Bachelor of Arts degree with High Honors from Rutgers University and her Medical Degree from the University of Medicine & Dentistry in Newark, New Jersey.  She completed her Family Practice Residency at the Medical University of South Carolina, in Charleston, South Carolina. She has her Master’s in Public Health and completed her Occupational & Environmental Medicine Residency and Fellowship in Heavy Metals at the Harvard School of Public Health in Boston, Massachusetts. She is a Fellow of the American Academy of Family Physicians. She is a Diplomat in Cannabinoid Medicine Certified by the American Academy of as a Cannabinoid Medicine, and a Medical Review Officer Certified by Medical Review Officer Certification Council.
 
She has received awards from the American College of Occupational & Environmental Medicine for her research project: “Occupational & Environmental Exposure to Lead in South India”; from The 7th World Ayurveda Conference & Arogya Expo for her presentation “Cannabis & The Therapeutic Uses” ; The Educational Achievement Award presented by Clover Leaf at Cannabis Business Award 2017; Award from High Times Inaugural Female 50 and Harvard T.H.Chan School Of Public Health, Lighting Talk Presenter – Misinfodemic – “Cannabis The Exit Drug”™

Dr Uma is the Founder/CEO for Global Health & Hygiene Solutions, LLC established in 2006, with a mission to promote wellness and prevent illness.  She is an educator, advocate, activist and speaks globally. She created the model TotalHealthCareTHC and runs an Independent Clinic at Uplifting Health & Wellness. where  she “Educates, Embraces, Empowers” her patients and public about preventive health and safe effective alternatives including cannabis as a plant medicine. Her mission is to change the Stigma regarding Cannabis and for the world to know about the Endocannabinoid system through education.

Dr Uma Says®, “Cannabis is not for everyone, yet it should be a first line option not the last resort” ™ “Cannabis is entrance to a better quality of life; it is an exit drug from pharmaceuticals, narcotics, alcohol and nicotine.”™  “Safety first, Do No Harm.”™ “Cannabis The Exit Drug®”

Ethan B. Russo, MD

Ethan B. Russo, MD

Ethan B. Russo, MD, CreDO Science , Ethan Russo, MD, is a board-certified neurologist, psychopharmacology researcher, and
author. He is the Founder and CEO of CReDo Science www.credo-science.com

Previously, he was Director of Research and Development of the International Cannabis
and Cannabinoids Institute (ICCI) based in Prague, Czech Republic:
https://www.icci.science. Medical Director of PHYTECS (2015-2017), a biotechnology
company researching and developing innovative approaches targeting the human
endocannabinoid system (http://www.phytecs.com), and from 2003-2014, he served as
Senior Medical Advisor, medical monitor and study physician to GW Pharmaceuticals,
United Kingdom for numerous Phase I-III clinical trials of Sativex® for alleviation of
cancer pain unresponsive to optimized opioid treatment and initial studies of Epidiolex®
for intractable epilepsy (https://www.gwpharm.com).

He graduated from the University of Pennsylvania (Psychology), and the University of
Massachusetts Medical School, before residencies in Pediatrics in Phoenix, Arizona and
in Child and Adult Neurology at the University of Washington in Seattle. He was a
clinical neurologist in Missoula, Montana for 20 years in a practice with a strong chronic
pain component. In 1995, he pursued a 3-month sabbatical doing ethnobotanical research
with the Machiguenga people in Parque Nacional del Manu, Peru.

He has held faculty appointments in Pharmaceutical Sciences at the University of
Montana, in Medicine at the University of Washington, and as visiting professor, Chinese
Academy of Sciences, Harvard University, and Johns Hopkins University.

He is a Past-President of the International Cannabinoid Research Society and is former
Chairman of the International Association for Cannabinoid Medicines. He serves on the
Scientific Advisory Board for the American Botanical Council. He is author of
Handbook of Psychotropic Herbs, co-editor of Cannabis and Cannabinoids:
Pharmacology, Toxicology and Therapeutic Potential, and author of The Last Sorcerer:
Echoes of the Rainforest. He was founding editor of Journal of Cannabis Therapeutics,
selections of which were published as books: Cannabis Therapeutics in HIV/AIDS,
Women and Cannabis: Medicine, Science and Sociology, Cannabis: From Pariah to
Prescription, and Handbook of Cannabis Therapeutics: From Bench to Bedside. He
has also published numerous book chapters, and over sixty articles in neurology, pain
management, cannabis, and ethnobotany. His research interests have included
correlations of historical uses of cannabis to modern pharmacological mechanisms,
phytopharmaceutical treatment of migraine and chronic pain, herbal synergy and
phytocannabinoid/terpenoid, serotonergic and vanilloid interactions.

He has consulted or lectured on these topics in 44 US states and Canadian provinces and 44 countries on six continents.

Gregory L. Gerdeman, Ph.D.

Gregory L. Gerdeman, Ph.D.

Gregory L. Gerdeman, Ph.D. , NASHCX , Dr. Greg Gerdeman is a neuroscientist, cannabinoid researcher and educator with expertise in the physiological actions of cannabis and the endocannabinoid system (ECS), as well as many facets of cannabis cultivation, extraction and medicinal use. His Ph.D. dissertation in Pharmacology from Vanderbilt University was one of the first studies to discover endocannabinoids acting as so-called “retrograde messengers” that regulate synaptic plasticity in the brain. These findings have become a foundation to modern understanding of the ECS as well as the neuroprotective and neuromodulating properties of cannabis. His writings, reflections and other digital content can be found at DrGerdeman.com.

Allyn Howlett, PhD

Allyn Howlett, PhD

Allyn Howlett, PhD, Wake Forest School of Medicine, Dr. Howlett is an expert on cannabinoid receptors, and is noted for her discovery of the brain cannabinoid receptor that is stimulated by Tetrahydrocannabinol (THC), the psychoactive compound in cannabis extracts. Dr. Howlett has worked with academic and pharmaceutical company chemists to study how THC, and synthetic drugs that are based upon THC, work in the brain. She has been active in the International Cannabinoid Research Society, and served as president in 2009-2010. She is currently an Associate Editor of the journal “Cannabis and Cannabinoid Research”. Dr. Howlett’s research is supported by a grant from the National Institute on Drug Abuse.

Dr. Bridget Williams M.D.

Dr. Bridget Williams M.D.

Dr. Bridget Williams M.D. , Green Harvest Health , Dr. Bridget Williams is an established family physician for nearly 20 years. She is the owner of Green Harvest Health, a medical cannabis clinic as well as Cole-Williams Coaching & Consulting. Combined together, Green Harvest Health is the only medical cannabis clinic in Ohio with life and wellness coaching incorporated into the practice. Dr. Bridget found a need for a trusted CBD to recommend to her patients. This led to the development of GHH CBD Medicinals which is a collection of high quality, well tested CBD products. Dr. Williams has spent her career guiding patients and colleagues in one of the largest health systems in the country. Her desire is to help others build awareness and a better life. Dr. Williams provides valuable talks on medical cannabis, CBD and balanced wellness across Ohio as well as teaching at the Cleveland School of Cannabis. By working with Dr. Williams, your life-balance will be established and your confidence will soar. It is through self discovery that habits can be broken and significant changes can be made.

Todd A Scattini

Todd A Scattini

Todd A Scattini, Blue Diamond Ventures, Todd is the Chairman of the Board of Blue Diamond Ventures and Global CEO of Harvest 360 Technologies. Todd is a retired Army Lieutenant Colonel who was a leading voice in medical cannabis legalization in Missouri working with KC NORML. He is active in Kansas as an advisory board member with the Kansas Cannabis Coalition. Todd brings strong leadership, global vision, and strategic direction to the cannabis conversation and enjoys engaging with thought leaders across the space.

His energy is drawn from his passion for the cannabis plant and a deep-seeded desire to unpack all its possibilities to heal patients and our planet, legitimately contribute to a global economy, and bring social justice to our society. He is committed to creating an effective and responsible legal cannabis market on a global scale. Todd is a West Point graduate and brings with him vast experience gained during a distinguished military career serving in a broad range of leadership positions in complex domestic and international settings, including five years of diplomatic service. He is an expert at providing consultative assistance to senior leaders; developing and managing relationships with key decision makers; managing multiple complex projects simultaneously and communicating organizational goals and objectives. He has laid the groundwork for high impact in the rapidly emerging European markets.

Cynthia L Northcutt

Cynthia L Northcutt

Cynthia L Northcutt, Kintsugi Solutions, LLC, Cynthia L. Northcutt, RN, BSN, JD

As a Registered Nurse and Attorney at Law, Cindy has worked in the medical and legal fields for over 30 years as an educator and advocate, and now practices exclusively in the areas of cannabis law and education. She participated in Missouri’s 2018 Amendment 2 campaign, now Article XIV of the Missouri Constitution, which legalized medical cannabis in Missouri, and she continues to fight for patient access and education.

Cindy is licensed to practice both law and nursing in the state of Missouri. She is an advisory board member and co-chair of the Missouri Medical Cannabis Trade Association’s Health, Education & Training Committee, and assisted with development of the first CME-granting medical cannabis primer for physicians by a cannabis trade association in the US. She is a member of the IACM, ASTM D37 (Cannabis) Committee, DCR, International Cannabis Bar Association, The Missouri Bar, MATA, Kansas Cannabis Coalition (advisory board member), and SMBA.

She is on the board of directors of the Mizzou Alumni Association, K9‘s for Camo (a nonprofit providing service dogs for veterans), and an advisor for Ayden’s Alliance (a nonprofit supporting cannabis access and education for children with serious health issues and veterans).

Paul E. Callicoat, M.D.

Paul E. Callicoat, M.D.

Paul E. Callicoat, M.D., Sarcoxie Nursery , Paul E. Callicoat, M.D.
Paul@sarcoxienursery.com

Paul E. Callicoat, M.D. is a retired board-certified interventional cardiologist from Joplin, MO. A fellow emeritus of the American College of Cardiology and member of the Missouri Medical Association, Paul currently serves as president of MoFarma 21, LLC, Sarcoxie Nursery, LLC; and is a co-owner of Hops 21, LLC.
After receiving a B.S. in Biology and B.A. in Chemistry from the University of North Carolina Wilmington, Paul attended medical school at the University of North Carolina School of Medicine. From there, he received his internal medicine training at St. Luke’s Hospital in Kansas City and cardiology training at St. Louis University Hospital. Paul went on to build a career as an esteemed cardiologist in Joplin, MO, and Grove, OK—becoming one of the first physicians in the U.S. to own and operate his own interventional cardiac catheterization lab.
In 2014, Paul sold his catheterization lab and cardiology practice. Soon after retirement, he was introduced to the medical cannabis industry by his son, Jonathon. Together they have built a state-of-the-art cannabis growing facility where they are currently licensed by the Missouri Department of Agriculture as an indoor hemp cultivator. They continue to develop strains of CBD producing hemp.
Dr. Callicoat is actively involved with the progression of marijuana laws in the state of Missouri. He strongly believes in the plants safety profile and ability to help alleviate many somatic and psychological symptoms.

Jahan Marcu, PhD

Jahan Marcu, PhD

Jahan Marcu, PhD, Marcu & Arora, Dr. Jahan Marcu has over 15 years of experience in cannabinoid research, policy, and operations. He has been a passionate advocate focused on consumer safety and the medical benefits of cannabis. He is also among a select group of professionals globally that has earned a PhD focused on the endocannabinoid system (with research on the structure and function of cannabinoid receptors, molecular pharmacology of the endocannabinoid system, and the role of the ECS in bone). Dr. Marcu has published basic and clinical research, and is also trained in psilocybin assisted therapy. Dr. Marcu is a founding partner at the consulting firm of Marcu & Arora, which provides life science consulting to the cannabis and psychedelics fields.

Dr. Marcu’s work has been instrumental to facilitating and supporting fact-based, scientific approaches vital to industry and patients. This has included research focused on solving the structure and function of cannabinoid receptors, the anti-cancer properties of cannabis compounds, as well as method development and validation for analyzing complex formulations. Furthermore, his efforts include the development of international certification and training programs, co-authoring American Herbal Pharmacopeia’s Cannabis Quality Control and Therapeutic Monographs, and assisting in the creation of the first standards for industry as a committee chairman of the cannabis committee for the American Herbal Products Association (AHPA). His dedication to consumer safety is further evident in his work to co-develop a biotech application to predict drug-drug interactions between cannabis and commonly prescribed pharmaceutical drugs. Additionally, Dr. Marcu co-authored one of the first product safety studies on CBD products.

He is also the founding Editor-In-Chief of the American Journal of Endocannabinoid Medicine. He is Adjunct Faculty at the University of the Sciences in Philadelphia, PA and teaches on the pharmacology of cannabis, regulation and finance for the cannabis industry, and other related subjects for pharmacists, health professionals and business majors. He is also founder and past-chair of the Cannabis Chemistry Sub-division of the American Chemical Society, the world’s largest and oldest professional scientific society. Further illustrating the recognition earned through his efforts, he has been asked to serve on multiple expert government advisory and trade association committees, as well as scientific organizations including ASTM (D37 Subcommittee chair), AHPA Cannabis committee (past-chair of laboratory sub-committee), ACS Cannabis Chemistry Subdivision (CANN), AOCS, AOAC, IACM(past BOD), and IMCPC (co-founder). He is also host and producer of the podcast, How to Launch an Industry.

Reflecting his dedication to the field, Dr. Marcu has received numerous awards including the Mahmoud Elsohly award for excellence in cannabis chemistry and the Billy Martin research achievement award from the International Cannabinoid Research Society for his work on THC and CBD synergy in aggressive brain cancers. He is also a court-qualified synthetic cannabinoid and cannabis expert. His work has been published and covered in publications such as Rolling Stone, Science, Nature, JAMA, the Washington Post, CNN, and many other media outlets.

Lisa Roark, MD

Lisa Roark, MD

Lisa Roark, MD, Roark Family Health, Cassville Dispensary, Dr. Lisa Roark received her combined BA/MD from University of Missouri-Kansas City. With over 15 years of medical experience, Dr. Roark practices in Southwest Missouri in all areas of Family Medicine, including pediatrics, women’s health, geriatrics, opiate addiction treatment, and medical marijuana physician certifications and patient management, where she is the sole owner and Medical Director of Roark Family Health.

Dr. Roark’s history as an advocate for medical marijuana education in Missouri, as well as an established community volunteer, led to the natural progression of becoming the sole owner of Cassville Dispensary, where she serves as CEO and Medical Director.

Dr. Roark lives in Cassville, MO with her husband and business partner, Griff. They have 4 beautiful children and enjoy boating, farming, hiking and yoga.

Tamara Netzel

Tamara Netzel

Tamara Netzel, Cruel Consequences Portraits of Misguided Law, Tamara Netzel Bio:

Awarded Cannabis Activist of the Year 2020 from Virginia NORML, and in the top 10 Who’s Who in Virginia Cannabis by District Fray Magazine, Tamara Netzel, a former middle school teacher who medically retired due to her Multiple Sclerosis, continues to educate communities to break the stigma of cannabis consumers and those who have been criminalized through her 501c3 nonprofit, Cruel Consequences: Portraits of Misguided Law. The growing portrait collection can be seen at cruelconsequences.org which is a collection of personal stories of people criminalized for cannabis, highlighting the collateral consequences of any cannabis charge leading to denial of employment, housing, child custody, college loans, and more well after court requirements are met. Netzel and her husband were featured on NBC Dateline in March 2017 for her testimony in the Virginia General Assembly for the unanimous vote on the medical cannabis law that opened up the state’s program to thousands of patients.

Cruel Consequences: Portraits of Misguided Law is a 501c3 national nonprofit portrait exhibit of people who have been harmed by marijuana prohibition. We take our traveling exhibit to community events and put these portraits in front of lawmakers and community leaders to break down the stigma and bring awareness of cannabis consumers who are prevented from pursuing their lives after a marijuana charge. Our portraits are also on the walls of 10 dispensaries across the U.S. to promote awareness of cannabis social justice alongside the growth of the cannabis industry in our Pursuit of Happiness Exhibit Program. Several Missouri cannabis businesses have our exhibits to include aliceCBD, Cassville Dispensary, and COCO Labs. Bass

April Hatch MSN, RN

April Hatch MSN, RN

April Hatch MSN, RN, Cannabis Care Team, April is a registered nurse with a Master’s in Public Health Nursing and has experience in acute care, public health, and education. As a member of multiple professional organizations, including the American Cannabis Nurses Association, the Society of Cannabis Clinicians, the Hospice & Palliative Nurses Association, and the American Holistic Nurses Association, she completed the first Medical Cannabis certificate program for healthcare professionals along with receiving hands-on training from Dr. Dustin Sulak in Maine. She is currently enrolled in the California Institute of Integral Studies Center for Psychedelic Therapies Certificate program. While education alone might illustrate April’s passion for plant medicine, her focus on cannabis began when her son suffered a traumatic brain injury and she saw the positive impact of cannabis in her son’s life. Over the past six years, April has been a tireless advocate for providing education, support, and advocacy to patients and the cannabis industry. Today, she serves in multiple capacities including the continuation of 1:1 patient consultations, developing and facilitating dispensary staff training, and her role teaching cannabis pharmacology at Saint Louis University. Despite wearing so many hats in the industry, April’s passion for educating others is what keeps her constantly moving forward and continuing to spread science-based evidence to the industry and patients at large.

Kevin Spelman

Kevin Spelman

Kevin Spelman, Health, Education & Research, Dr. Kevin Spelman, PhD is a clinician, a researcher and an industry expert in botanical medicine over the last 30 years. He was formerly a postdoctoral fellow at the National Institute on Aging researching the molecular biology of brain cancer and ovarian cancer. He also predicted and identified novel cannabimimetic ligands from Zanthoxylum spp. while at NIH. In addition, he was a Marie Curie Research Fellow in the European Union and researched novel chemotherapy, including medicinal plants, against malaria. His doctoral work connected pharmacological targets for metabolic and immunological function and elucidated a novel endocannabinoids target for Echinacea spp. Dr. Spelman currently has published 29 publications in peer reviewed scholarly and scientific journals and is the author of six chapters in six books. He currently directs Health, Education & Research a consulting company for the natural products and cannabis industry which offers formulation, product development and other services. Dr. Spelman is a cofounder of the first accredited master’s degree in Clinical Herbal Medicine at Maryland University of Integrative Health and was the Clinical Chair for four years. He has served as adjunct professor at three of the four naturopathic medical schools in the U.S. and developed curriculum, courses and lectured at other universities and medical schools such as Georgetown, Johns Hopkins and Mass College of Pharmacy & Health Sciences during his many years focusing on the pharmacology of botanical medicines. Dr. Spelman also publishes an audio science journal entitled The Spelman Report: PhytoPharmacology Review that reviews clinically relevant research on natural products.

The 15th National Clinical Conference on Cannabis Therapeutics

Patients Out of Time

June 9th to June 11th, 2022.

THE ENDOCANNABINOID SYSTEM & BEYOND

Unity Temple on the Plaza
Kansas City, Missouri

This conference, delivered in person and virtually (hybrid) provides educational tracks for healthcare professionals eligible for CE accreditation as well as educational sessions for the public.

Cannabis 101 Workshop, 2.75 Credits  |  Main Conference, 14 Credits

Accredited Banner

Medicine- AMA PRA Category 1 Nursing- ANCC Contact Hours Pharmacy- ACPE Physician Assistant - AAPA Psychology- APA Social work- ASWB MOC II- ABA MOC II- ABIM MOC II- ABP

Jointly Provided by

the University of Virginia School of Medicine & School of Nursing
& the Academy of Cannabis Education

Pin It on Pinterest

Share This